1. Chen LY, Lennon RJ, Grantham JA, et al. In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction. Am. J. Cardiol. 2005; 95: 349-54.
2. Tarasov RS, Ganiukov VI, Krotikov JuV, et al. Multiple stents in comparison to the landmark revascularization in patients with STEMI in multivessel coronary lesions. Interventional cardiology 2011/2012; 27/28: 10-7. Russia (Тарасов Р. С., Ганюков В. И., Кротиков Ю. В. и др. Множественное стентирование в сравнении с этапной реваскуляризацией у больных инфарктом миокарда с элевацией сегмента ST при многососудистом поражении коронарного русла. Интервенционная кардиология 2011/2012; 27/28: 10-7).
3. Ioseliany DG, Kostyanov IJu, Vasil’ev PS, et al. The influence of the term of reperfusion myocardium on the nearest and furthest prognosis for the patients with STEMI. Interventional cardiology 2013; 33: 22-33. Russia (Иоселиани Д. Г., Костянов И. Ю., Васильев П. С. и др. Влияние сроков реперфузии миокарда на ближайший и отдаленный прогноз заболевания у больных ОИМ с подъемом сегмента ST (ОИМ-ST). Интервенционная кардиология 2013; 33: 22-33).
4. D'Oliveira R, Gersh BJ, Lima EG, et al. Effect of Complete Revascularization on 10-Year Survival of Patients With Stable Multivessel Coronary Artery Disease: MASS II Trial. Circulation. 2012; 126: 158-63.
5. The BARI 2D Study Group. A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. N. Engl. J. Med. 2009; 360: 2503-15.
6. Frye RL, August Ph, Brooks MM, et al. A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. N. Engl. J. Med. 2009; 360: 2503-15.
7. Puskas JD, Pawale A, Sharma SK Hybrid coronary revascularization. A new treatment paradigm for selected patients with multivessel coronary artery disease. JACC. 2014; 7(10): 1284-6.
8. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur. Heart J. 2005; 26(8): 804-47.
9. Windecker S, Kolh Ph, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 2014; 35(37): 2541-619.
10. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 2009; 360: 961-72.
11. Bonaca MB, Steg PG, Feldman LJ, et al. Antithrombotics in Acute Coronary Syndromes. JACC. 2009; 54(11): 969-84.
12. PRAMI Trial: Complete revascularisation during ST segment elevation myocardial infarction is beneficial. British Cardiovascular Society http://www.bcs.com/pages/news_full.asp?NewsID=19792175 (9 October 2013).
13. Rastan AJ, Walther T, Falk V, et al. Does reasonable incomplete surgical revascularization affect early or long-term survival in patients with multivessel coronary artery disease receiving left internal mammary artery bypass to left anterior descending artery? Circulation 2009; 120: 70-7.
14. Caputo RP, JA, Tremmel JA, et al. Transradial Arterial Access for Coronary and Peripheral Procedures: Executive Summary by the Transradial Committee of the SCAI. Catheterization and Cardiovascular Interventions 2011; 78: 823-39.
15. Khattab AA, Abdel-Wahab M, Rother C, et al. Multivessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single-center experience. Clin. Res. Cardiol. 2008; 97: 32-8.
16. Kong JA, Chou ET, Minutello RM, et al. Safety of single versus multi-vessel coronary artery disease: report from the New-York State Angioplasty Registry. Coron. Artery Dis. 2006; 17(1): 71-5.